Orally Administrated JBM-TC4 Prevents Acute Radiodermatitis in Breast Cancer Patients
Clinical trial NCT02289365 · UNKNOWN
Trial details
- NCT number
- NCT02289365
- Sponsor
- Joben Bio-Medical Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-11-01
- Primary completion
- 2016-12-01
- Enrollment
- 120
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.